Investors with a more opportunistic profile extend the bullish rally of the creator of the only suitable vaccine for monkeypox as infections increase, while bearish hedge funds move into action on the magnitude of the increases.
The rate of spread of monkeypox infections worries health authorities, and gives free rein to speculation about its scope in the stock market. Information on new cases of global escalation continues
5